drugset / Trial / NCT01948895
Desvenlafaxine Monotherapy in Dysthymia
NaSingle-groupOpen-labelTreatment
Summary
This multi-centred study will be conducted at two centres. The design will be an open label, flexible-dose study. This investigation will evaluate the efficacy of Desvenlafaxine monotherapy for patients who meet diagnostic criteria for dysthymia.
Timeline
- Start
- 2012-08
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | — |
| Subject | Desvenlafaxine | Other / unclassified | 100 mg | — |